UNSPSC 51384002: Chlorthenoxazine

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C10H10ClNO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KA0B657LV3, chemically known as 4-oxo-2-(beta-chloroethyl)-2,3-dihydrobenzo-1,3-oxazine but generally known as chlorthenoxazine, which bears US NIH Compound Identifier 8602. European Medicines Agency schedules Chlorthenoxazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06214MIG.

UNSPSC 51384002 Chlorthenoxazine is a Commodity code that state and local governments use to classify pharmaceutical procurement, though recent solicitations under this code reflect broader pharmaceutical and drug-related product acquisition rather than the specific active ingredient alone. State and local health agencies, including county health departments and state pharmacy benefit programs, solicit under this code for naloxone, drug deactivation systems, generic pharmaceuticals, and over-the-counter products distributed through established wholesaler networks and community health initiatives. The work involves competitive bidding for pharmaceutical supply contracts with multi-year terms, quarterly or ongoing delivery schedules, FDA compliance certification, Drug Supply Chain Security Act adherence, current Good Manufacturing Practices validation, and manufacturer pricing negotiation through authorized distribution channels.

Recent activity shows Seminole County, Florida (IFB60459723LAS, posted June 30, 2026, response due July 26, 2023) procuring 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford; the Texas Health and Human Services Commission (HHS0017013, posted April 3, 2026) issued a Request for Information to explore direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager channels; and the Minnesota Multistate Cooperative Purchasing Alliance (S1070000015802, posted January 20, 2026, response due March 26, 2026) solicited generic multi-source pharmaceuticals and OTC products for distribution across participating state and local government facilities in Minnesota and Oregon through three authorized wholesalers, with awards effective July 1, 2026. Procurement activity spans state health agencies, county health departments, and cooperative purchasing vehicles, with geographic concentration in Florida, Texas, and Minnesota, reflecting health department demand for emergency response medications and state pharmacy benefit program modernization efforts.